Internal Medicine, Pulmonary Disease · Chicago, IL
NPI
1497912091
Since 2008
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
5841 S Maryland Ave Mc6067, University of Chicago
Chicago, IL, 60637
Phone (773) 702-9660
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.8M
1,941 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug David R Brush prescribed most often to Medicare patients was Breyna (Budesonide/Formoterol Fumarate), with 277 prescriptions and refills. In total David R Brush wrote 1,941 Medicare prescriptions that cost $1.8M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-02-11.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Breyna Budesonide/Formoterol Fumarate | 277 | 367 | 78 | $50K |
| Prednisone Generic | 205 | 337 | 79 | $2,060 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 149 | 170 | 51 | $2,891 |
| Wixela Inhub Fluticasone Propion/Salmeterol | 108 | 199 | 40 | $19K |
| Ofev Nintedanib Esylate | 92 | 92 | 11 | $1.1M |
| Alvesco Ciclesonide | 82 | 140 | 34 | $12K |
| Montelukast Sodium Generic | 79 | 223 | 32 | $840 |
| Azithromycin Generic | 77 | 168 | 37 | $1,097 |
| Spiriva Respimat Tiotropium Bromide | 77 | 201 | 34 | $58K |
| Pirfenidone Generic | 71 | 75 | Under 11 | $21K |
| Advair Hfa Fluticasone Propion/Salmeterol | 46 | 70 | 14 | $26K |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 44 | 131 | 19 | $40K |
| Ipratropium Bromide Generic | 37 | 46 | 18 | $816 |
| Mycophenolate Mofetil Generic | 35 | 87 | 12 | $4,223 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 33 | 66 | 12 | $252 |
Brand drugs: 669 claims; generic drugs: 1,272 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to David R Brush were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.